ABC Still Optimistic On Fee-For-Service Despite Dropping Earnings Estimates
This article was originally published in The Pink Sheet Daily
Executive Summary
AmerisourceBergen still aims to have most manufacturers under fee-for-service agreements by the end of 2005. Although ABC has not set a March 31 deadline for fee-for-service contracts like Cardinal and McKesson, CEO Yost says "there is nothing in the market place that would imply that we are slower" at making the transition.
You may also be interested in...
ABC's Oncology Business Still Strong Despite Medicare Reimbursement Changes
AmerisourceBergen is "cautiously" optimistic about the impact of oncology reimbursement on its Specialty Group business through the rest of the calendar year. The wholesaler previously said it expected the change in Medicare Part B drug reimbursement to have a negative effect on revenues.
ABC's Oncology Business Still Strong Despite Medicare Reimbursement Changes
AmerisourceBergen is "cautiously" optimistic about the impact of oncology reimbursement on its Specialty Group business through the rest of the calendar year. The wholesaler previously said it expected the change in Medicare Part B drug reimbursement to have a negative effect on revenues.
Cardinal Sees No Rx Distribution Disruptions After April 1 Fee-For-Service Deadline
Most drug manufacturers have agreed in principle to fee-for-service distribution contracts, Cardinal CEO Walter says. Negotiations are now focused on price, not the methodology for paying wholesalers, he says.